The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2016 | ESMO 2016: Press brief on the key messages of ESMO and its vision for the future
Fortunato Ciardiello, MD, PhD of Second University of Naples, Naples, Italy gives a press brief about the key messages of the European Society of Medical Oncology (ESMO) in the context of helping patients and doctors. He explains that collaboration is key and a true integrative approach is needed; he names the Danish cancer plan as an example of an integrative model. Prof. Ciardiello explains what an integrated and sustainable approach is and the role of the ESMO congress. Further, he presents the ESMO 2020 vision.
Recorded at the 2016 annual meeting of the European Society of Medical Oncology (ESMO), held in Copenhagen, Denmark.
